(Q37827408)

23 August 2017

1 reference

title

Immune modulation in heart failure: past challenges and future hopes (English)

1 reference

23 August 2017

0 references

Gerardo García-Rivas

2

0 references

Guillermo Torre-Amione

series ordinal

3

object named as

Guillermo Torre-Amione

1 reference

23 August 2017

author name string

Jose H Flores-Arredondo

series ordinal

1

1 reference

23 August 2017

publication date

1 March 2011

1 reference

Current heart failure reports

23 August 2017

published in

1 reference

23 August 2017

volume

8

1 reference

23 August 2017

issue

1

1 reference

23 August 2017

page(s)

28-37

1 reference

Adipose tissue as an endocrine organ

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0044-2

Cytokine-induced modulation of cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0044-2

Heart failure, oxidative stress, and ion channel modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0044-2

Synergy between tumor necrosis factor and bacterial products causes hemorrhagic necrosis and lethal shock in normal mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0044-2

Differential expression of TNF-alpha, IL-6, and IGF-1 by graded mechanical stress in normal rat myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0044-2

Chronic hypoxia modulates the interleukin-1beta-stimulated inducible nitric oxide synthase pathway in cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0044-2

A human inhibitor of tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0044-2

Oxidative mechanism and homeostasis of proteinase/antiproteinase in congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0044-2

Nuclear Factor (NF) kappaB polymorphism is associated with heart function in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0044-2

Inflammatory markers and incident heart failure risk in older adults: the Health ABC (Health, Aging, and Body Composition) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0044-2

The interleukin-6/interleukin-6-receptor system is activated in donor hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0044-2

Do cytokines enable risk stratification to be improved in NYHA functional class III patients? Comparison with other potential predictors of prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0044-2

Interleukin-1 beta modulates the growth and phenotype of neonatal rat cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0044-2

Association of ST2 levels with cardiac structure and function and mortality in outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0044-2

Soluble ST2 for predicting sudden cardiac death in patients with chronic heart failure and left ventricular systolic dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0044-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0044-2

Myocarditis: infection versus autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0044-2

Viral endomyocardial infection is an independent predictor and potentially treatable risk factor for graft loss and coronary vasculopathy in pediatric cardiac transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0044-2

An approach to endomyocardial biopsy interpretation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0044-2

Cardiac troponins and autoimmunity: their role in the pathogenesis of myocarditis and of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0044-2

Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0044-2

Cardiac autoantibodies to myosin and other heart-specific autoantigens in myocarditis and dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0044-2

A peptide fragment of beta cardiac myosin heavy chain (beta-CMHC) can provoke autoimmune myocarditis as well as the corresponding alpha cardiac myosin heavy chain (alpha-CMHC) fragment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0044-2

Viral myocarditis: from the perspective of the virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0044-2

Aldosterone and not plasminogen activator inhibitor-1 is a critical mediator of early angiotensin II/NG-nitro-L-arginine methyl ester-induced myocardial injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0044-2

Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0044-2

Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failu

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0044-2

Broad modulation of tissue responses (immune activation) by celacade may favorably influence pathologic processes associated with heart failure progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0044-2

Effects of a novel immune modulation therapy in patients with advanced chronic heart failure: results of a randomized, controlled, phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0044-2

Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0044-2

A study to assess the effects of a broad-spectrum immune modulatory therapy on mortality and morbidity in patients with chronic heart failure: the ACCLAIM trial rationale and design

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0044-2

Therapy of ischemic cardiomyopathy with the immunomodulating agent pentoxifylline: results of a randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0044-2

Simvastatin decreases myocardial tumor necrosis factor alpha content in heart transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0044-2

Rosuvastatin in older patients with systolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0044-2

Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0044-2

Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0044-2

Therapeutic apheresis in autoimmune and rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0044-2

Plasma exchange: why we do what we do.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0044-2

Tumor Necrosis Factor Soluble Receptors in Patients With Various Degrees of Congestive Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0044-2

Negative inotropic effects of cytokines on the heart mediated by nitric oxide

21 January 2018

1 reference

12 December 2020

Potential role of humoral immunity in cardiac dysfunction of patients suffering from dilated cardiomyopathy

1 reference

12 December 2020

Elevated circulating levels of tumor necrosis factor in severe chronic heart failure

1 reference

12 December 2020

Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy

1 reference

12 December 2020

Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

1 reference

12 December 2020

Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure

1 reference

12 December 2020

Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart

1 reference

12 December 2020

Systemic inflammation in patients with heart failure

1 reference

12 December 2020

Human cardiac inflammatory responses triggered by Coxsackie B viruses are mainly Toll-like receptor (TLR) 8-dependent

1 reference

12 December 2020

Endotoxin and cytokines induce direct cardiodepressive effects in mammalian cardiomyocytes via induction of nitric oxide synthase

1 reference

12 December 2020

Activation of the cardiac interleukin-6 system in advanced heart failure

1 reference

12 December 2020

Expression and functional significance of tumor necrosis factor receptors in human myocardium

1 reference

12 December 2020

Haemodynamic, neuroendocrine and metabolic correlates of circulating cytokine concentrations in congestive heart failure

1 reference

12 December 2020

A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity.

1 reference

12 December 2020

T regulatory cells: sentinels against autoimmune heart disease

1 reference

12 December 2020

Regulating viral myocarditis: allografted regulatory T cells decrease immune infiltration and viral load

1 reference

12 December 2020

The molecular phenotype of heart transplant biopsies: relationship to histopathological and clinical variables

1 reference

12 December 2020

Crossroads of cytokine signaling--the chase to stop muscle cachexia

1 reference

12 December 2020

Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure. Relation to nitric oxide-dependent vasodilation in the forearm circulation

1 reference

12 December 2020

Therapeutic plasma exchange a potential strategy for patients with advanced heart failure

1 reference

12 December 2020

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

12 December 2020

Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats

1 reference

12 December 2020

Immunoadsorption in dilated cardiomyopathy: 6-month results from a randomized study

1 reference

12 December 2020

Adenosine inhibits lipopolysaccharide-induced cardiac expression of tumor necrosis factor-alpha

1 reference

12 December 2020

10.1007/S11897-010-0044-2

Identifiers

DOI

1 reference

23 August 2017

1 reference